MedTrace Logo

Assessing Urinary Hormones in Female Cancer Survivors

NCT03197532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2020-11-20

No results posted yet for this study

Summary

Women of late to mid reproductive age may participate in a study using novel methodology to identify subtle changes in the reproductive endocrine axis via daily urine hormone analysis, which may have important implications for reproduction and may signal reproductive senescence.

Conditions

  • Effects of Chemotherapy

Sponsors & Collaborators

Principal Investigators

  • Clarisa R Gracia, MD, MSCE · University of Pennsylvania, Reproductive Research Unit

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03197532 on ClinicalTrials.gov